These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29094675)

  • 21. Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study.
    Khadka S; Meda SA; Stevens MC; Glahn DC; Calhoun VD; Sweeney JA; Tamminga CA; Keshavan MS; O'Neil K; Schretlen D; Pearlson GD
    Biol Psychiatry; 2013 Sep; 74(6):458-66. PubMed ID: 23746539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome.
    Hamilton HK; Roach BJ; Bachman PM; Belger A; Carrion RE; Duncan E; Johannesen JK; Light GA; Niznikiewicz MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cannon TD; Mathalon DH
    JAMA Psychiatry; 2019 Nov; 76(11):1187-1197. PubMed ID: 31389974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives.
    Meda SA; Gill A; Stevens MC; Lorenzoni RP; Glahn DC; Calhoun VD; Sweeney JA; Tamminga CA; Keshavan MS; Thaker G; Pearlson GD
    Biol Psychiatry; 2012 May; 71(10):881-9. PubMed ID: 22401986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of auditory target P300 subcomponents in psychosis: Differential diagnosis, symptom profiles, and course.
    Perlman G; Foti D; Jackson F; Kotov R; Constantino E; Hajcak G
    Schizophr Res; 2015 Jul; 165(2-3):145-51. PubMed ID: 25934167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients.
    Braverman ER; Blum K; Hussman KL; Han D; Dushaj K; Li M; Marin G; Badgaiyan RD; Smayda R; Gold MS
    PLoS One; 2015; 10(8):e0133609. PubMed ID: 26244349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auditory and Visual Oddball Stimulus Processing Deficits in Schizophrenia and the Psychosis Risk Syndrome: Forecasting Psychosis Risk With P300.
    Hamilton HK; Woods SW; Roach BJ; Llerena K; McGlashan TH; Srihari VH; Ford JM; Mathalon DH
    Schizophr Bull; 2019 Sep; 45(5):1068-1080. PubMed ID: 30753731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
    Hill SK; Reilly JL; Keefe RS; Gold JM; Bishop JR; Gershon ES; Tamminga CA; Pearlson GD; Keshavan MS; Sweeney JA
    Am J Psychiatry; 2013 Nov; 170(11):1275-84. PubMed ID: 23771174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated Aging of Functional Brain Networks Supporting Cognitive Function in Psychotic Disorders.
    Sheffield JM; Rogers BP; Blackford JU; Heckers S; Woodward ND
    Biol Psychiatry; 2019 Aug; 86(3):240-248. PubMed ID: 30739807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auditory P300 event related potentials in acute and transient psychosis-Comparison with schizophrenia.
    Sahoo S; Malhotra S; Basu D; Modi M
    Asian J Psychiatr; 2016 Oct; 23():8-16. PubMed ID: 27969085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study.
    Fusar-Poli P; Crossley N; Woolley J; Carletti F; Perez-Iglesias R; Broome M; Johns L; Tabraham P; Bramon E; McGuire P
    J Psychiatry Neurosci; 2011 Jul; 36(4):239-48. PubMed ID: 21299920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Speed of facial affect intensity recognition as an endophenotype of first-episode psychosis and associated limbic-cortical grey matter systems.
    Dean AM; Goodby E; Ooi C; Nathan PJ; Lennox BR; Scoriels L; Shabbir S; Suckling J; Jones PB; Bullmore ET; Barnes A
    Psychol Med; 2013 Mar; 43(3):591-602. PubMed ID: 22703698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auditory P300 in individuals clinically at risk for psychosis.
    Frommann I; Brinkmeyer J; Ruhrmann S; Hack E; Brockhaus-Dumke A; Bechdolf A; Wölwer W; Klosterkötter J; Maier W; Wagner M
    Int J Psychophysiol; 2008 Dec; 70(3):192-205. PubMed ID: 18700155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P300 and neuropsychological tests as measures of aging: scalp topography and cognitive changes.
    Fjell AM; Walhovd KB
    Brain Topogr; 2001; 14(1):25-40. PubMed ID: 11599530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescent Verbal Memory as a Psychosis Endophenotype: A Genome-Wide Association Study in an Ancestrally Diverse Sample.
    Wang B; Giannakopoulou O; Austin-Zimmerman I; Irizar H; Harju-Seppänen J; Zartaloudi E; Bhat A; McQuillin A; Kuchenbäcker K; Bramon E
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2.
    Turetsky BI; Dress EM; Braff DL; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Light G
    Schizophr Res; 2015 Apr; 163(1-3):53-62. PubMed ID: 25306203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decomposing P300 into correlates of genetic risk and current symptoms in schizophrenia: An inter-trial variability analysis.
    Kim M; Lee TH; Kim JH; Hong H; Lee TY; Lee Y; Salisbury DF; Kwon JS
    Schizophr Res; 2018 Feb; 192():232-239. PubMed ID: 28400070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories.
    Reilly JL; Frankovich K; Hill S; Gershon ES; Keefe RS; Keshavan MS; Pearlson GD; Tamminga CA; Sweeney JA
    Schizophr Bull; 2014 Sep; 40(5):1011-21. PubMed ID: 24080895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.
    Şevik AE; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Gürses N; Yıldız M
    Schizophr Res; 2011 Aug; 130(1-3):195-202. PubMed ID: 21592733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological Evidence of Auditory and Cognitive Processing Deficits in Parkinson Disease.
    Folmer RL; Vachhani JJ; Riggins A
    Biomed Res Int; 2021; 2021():6610908. PubMed ID: 34239927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.